Lisdexamfetamine is a central nervous system stimulant used primarily to treat attention deficit hyperactivity disorder and binge eating disorder. As a prodrug of dextroamphetamine, it requires enzymatic… Read more
Lisdexamfetamine is a central nervous system stimulant used primarily to treat attention deficit hyperactivity disorder and binge eating disorder. As a prodrug of dextroamphetamine, it requires enzymatic hydrolysis in the body to release the active stimulant, which works by increasing synaptic dopamine and norepinephrine levels. To support the rigorous demands of pharmaceutical research and development, this category provides high-quality reference standards essential for analytical testing. These include lisdexamfetamine impurities and metabolites, which are critical for accurate impurity profiling and verifying the precision of analytical methods. Additionally, the collection features stable isotope labelled compounds, which serve as vital internal standards for mass spectrometry-based assays. Pharmaceutical laboratories rely on these precise, documented materials to perform reliable quality control, ensure regulatory compliance, and confirm the stability and purity of drug formulations throughout the development lifecycle.